Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-02-22
2011-02-22
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S648000
Reexamination Certificate
active
07893091
ABSTRACT:
This invention concerns compositions for the treatment of urinary frequency, urinary urgency and urinary incontinence comprising (R)-N-[4-[2-[[2-hydroxy-2-(pyridin-3 -yl)ethyl]amino]ethyl]phenyl]-4-[4-(4-trifluoromethylphenyl)thiazol-2-yl]benzenesulfonamideand pharmaceutically acceptable salts thereof. In another aspect, this invention concerns combination therapy for urinary frequency, urinary urgency and urinary incontinence wherein one of the active agents is (R)-N-[4-[2-[[2-hydroxy-2-(pyridin-3-yl)ethyl]amino]ethyl]phenyl]-4-[4-(4-trifluoromethylphenyl)thiazol-2-yl]benzenesulfonamide and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 2004/0248979 (2004-12-01), Brettman et al.
patent: WO 98/32753 (1998-07-01), None
patent: WO 2005/032464 (2005-04-01), None
patent: WO 2005/073191 (2005-08-01), None
patent: WO 2006/002117 (2006-01-01), None
Gottesdiener Keith M.
Green Stuart A.
MacIntyre Euan
Camaro Valerie J.
Merck Sharp & Dohme Corp.
Spivack Phyllis G.
Zhao Yong
LandOfFree
Combination therapy for the treatment of urinary frequency,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy for the treatment of urinary frequency,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for the treatment of urinary frequency,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2646908